m⁶A-driven transcriptomic rewiring in tumor immune surveillance.

Area of Science:

• Molecular Biology
• Epigenetics
• Immunology

Background:

• RNA molecules undergo extensive post-transcriptional modifications.
• N6-methyladenosine (m⁶A) is the most abundant internal modification on eukaryotic messenger RNAs.
• m⁶A dynamics involve writers, erasers, and readers that regulate gene expression.

Purpose of the Study:

• To review mechanisms of m⁶A deposition and its impact on mRNA.
• To explore the role of m⁶A in antitumor immune responses.
• To discuss targeting m⁶A pathways for enhanced cancer immunotherapy.

Main Methods:

• Literature review of m⁶A mechanisms and functions.
• Analysis of m⁶A's role in immune responses.
• Examination of therapeutic strategies targeting m⁶A regulators.

Main Results:

• m⁶A modification significantly influences mRNA fate and gene expression.
• m⁶A plays a critical role in shaping antitumor immunity.
• Targeting m⁶A pathways offers potential to boost immunotherapy efficacy.

Conclusions:

• m⁶A is a crucial regulator of gene expression with significant implications for cancer immunology.
• Developing drugs targeting m⁶A regulators is a promising avenue for cancer therapy.